Silk Road Medical Inc. Stock News

SUNNYVALE, Calif., April 09, 2024 (GLOBE NEWSWIRE) -- Silk Road Medical, Inc. (Nasdaq: SILK), a company focused on reducing the risk of stroke and its devastating impact, today announced it will repor

Silk Road Medical (SILK) announces its latest launch of ENROUTE Transcarotid Neuroprotection System PLUS, which is likely to aid in TCAR procedures.

Silk Road Medical (SILK) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

Silk Road Medical (SILK) announces the launch of its Tapered ENROUTE Transcarotid Stent System to hospitals in the United States.

Silk Road Medical, Inc (SILK) Q4 2023 Earnings Call Transcript

Silk Road Medical (SILK) came out with a quarterly loss of $0.33 per share versus the Zacks Consensus Estimate of a loss of $0.40. This compares to loss of $0.34 per share a year ago.

SUNNYVALE, Calif., Feb. 07, 2024 (GLOBE NEWSWIRE) -- Silk Road Medical, Inc. (Nasdaq: SILK), a company focused on reducing the risk of stroke and its devastating impact, today announced it will report

Silk Road Medical (SILK) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price in

SUNNYVALE, Calif., Dec. 20, 2023 (GLOBE NEWSWIRE) -- Silk Road Medical, Inc. (Nasdaq: SILK), a company focused on reducing the risk of stroke and its devastating impact, today announced the company wi

Silk Road Medical, Inc (NASDAQ:SILK ) Q3 2023 Earnings Conference Call November 8, 2023 4:30 PM ET Company Participants Marissa Bych - Gilmartin Group, Director, Investor Relations Jack Lasersohn - Ch

SUNNYVALE, Calif., Oct. 26, 2023 (GLOBE NEWSWIRE) -- Silk Road Medical, Inc. (Nasdaq: SILK), a company focused on reducing the risk of stroke and its devastating impact, today announced it will report

Silk Road Medical is a medical device company that focuses on preventing strokes. The company released preliminary third-quarter numbers and reduced yearly revenue guidance.

Silk Road Medical (NASDAQ:SILK) stock halved in value at the start of Wednesday's trading after an after-hours profit warning. The company, which has developed a treatment for carotid artery disease,

Silk Road Medical (NASDAQ: SILK ) stock is falling hard on Wednesday after the medical device company released preliminary earnings results for Q3 2023. A press release from Silk Road Medical reveals

Two pieces of news are weighing on shares of the medical devices company.